Meet Vascular & Endovascular Surgeon Dr. Gregory Magee

Why It Matters

Personalized, minimally invasive vascular procedures accelerate recovery, cut costs, and deepen patient trust, heralding a transformative trend in surgical care.

Key Takeaways

• Minimally invasive techniques enable next‑day discharge after vascular surgery.
• Surgeon emphasizes personalized grafts tailored to each patient’s anatomy.
• “Ship in a bottle” analogy illustrates modular, repeatable graft construction.
• Pre‑operative simulation improves outcomes and patient confidence significantly.
• Long‑term surgeon‑patient relationships foster trust for chronic vascular care.

Summary

Dr. Gregory Magee, system chief of vascular and endovascular surgery, explains his division’s comprehensive approach—from the neck to the toes—while highlighting the rapid evolution toward minimally invasive procedures. He notes that patients can undergo operations and return home the next day through two tiny needle‑hole incisions, a stark contrast to traditional open surgery.

Magee emphasizes a patient‑centric model that creates custom grafts tailored to individual anatomy. Using a “ship in a bottle” metaphor, he describes assembling modular graft components—sometimes as few as three, sometimes fifteen or more—directly within the patient, allowing future revisions to be built inside existing structures. Pre‑operative simulation and detailed planning further enhance outcomes and patient confidence.

He underscores the lifelong nature of vascular disease, fostering deep surgeon‑patient relationships built on trust and understanding. 'We build the graft inside the patient, and if problems arise we can build another ship inside the previous one,' he explains, illustrating the iterative, minimally invasive strategy.

The approach signals a broader shift in surgical care: personalized, minimally invasive solutions that reduce recovery time, lower costs, and strengthen patient loyalty. As technology advances, such tailored interventions are poised to become standard, reshaping vascular surgery’s future.

Original Description

Gregory A. Magee, MD is a vascular and endovascular surgeon and System Chief of the Division of Vascular and Endovascular Surgery at NYU Langone Health. He cares for people with diseases of the blood vessels throughout the body, including aortic disease and peripheral artery disease.

Dr. Magee chose vascular surgery because it allows him to build long-term relationships with patients managing lifelong conditions. He takes time to understand each person’s concerns, priorities, and goals before recommending treatment. He believes that clear communication and trust are essential, especially when patients are facing complex decisions about their health.

Expertise

Dr. Magee treats conditions including

• Aortic aneurysms and other aortic diseases

• Peripheral artery disease affecting the legs and feet

• Carotid artery disease affecting blood flow to the brain

• Blocked or narrowed arteries

• Complications of prior vascular procedures

Dr. Magee specializes in minimally invasive endovascular techniques that use small incisions and advanced imaging to treat vascular disease from inside the blood vessels. Many procedures involve placing customized stent grafts designed to fit a patient’s unique anatomy. When minimally invasive options are not the safest or most effective choice, he also performs open vascular surgery. His approach is always tailored to the individual, with careful planning and simulation of procedures in advance whenever possible.

Care is coordinated through a multidisciplinary team that may include specialists in cardiology, interventional radiology, neurology, wound care, and primary care. Together, they create comprehensive treatment plans that address both immediate concerns and long-term vascular health.

Learn more about Dr. Magee: https://nyulangone.org/doctors/1841486222/gregory-a-magee